117 related articles for article (PubMed ID: 22843073)
21. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.
Gsur A; Bernhart K; Baierl A; Feik E; Führlinger G; Hofer P; Leeb G; Mach K; Micksche M
Cancer Epidemiol; 2011 Oct; 35(5):e38-41. PubMed ID: 21612998
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.
Dai Q; Luo H; Li XP; Huang J; Zhou TJ; Yang ZH
Mutagenesis; 2015 May; 30(3):441-9. PubMed ID: 25690281
[TBL] [Abstract][Full Text] [Related]
23. Effect of MLH1 -93G>A on gene expression in patients with colorectal cancer.
Funck A; Santos JC; Silva-Fernandes IJ; Rabenhorst SH; Martinez CA; Ribeiro ML
Med Oncol; 2014 Sep; 31(9):160. PubMed ID: 25115745
[TBL] [Abstract][Full Text] [Related]
24. Influence of DNA repair gene polymorphisms on the initial repair of MMS-induced DNA damage in human lymphocytes as measured by the alkaline comet assay.
Ryk C; Routledge MN; Allan JM; Wild CP; Kumar R; Lambert B; Hou S
Environ Mol Mutagen; 2008 Dec; 49(9):669-75. PubMed ID: 18627000
[TBL] [Abstract][Full Text] [Related]
25. Mismatch repair polymorphisms and the risk of colorectal cancer.
Berndt SI; Platz EA; Fallin MD; Thuita LW; Hoffman SC; Helzlsouer KJ
Int J Cancer; 2007 Apr; 120(7):1548-54. PubMed ID: 17205513
[TBL] [Abstract][Full Text] [Related]
26. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
27. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
[TBL] [Abstract][Full Text] [Related]
28. Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients.
Dimberg J; Skarstedt M; Slind Olsen R; Andersson RE; Matussek A
APMIS; 2016 Sep; 124(9):736-40. PubMed ID: 27328741
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
[TBL] [Abstract][Full Text] [Related]
30. Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.
Martínez-Urueña N; Macías L; Pérez-Cabornero L; Infante M; Lastra E; Cruz JJ; Miner C; González R; Durán M
Colorectal Dis; 2013 Mar; 15(3):e118-23. PubMed ID: 23374646
[TBL] [Abstract][Full Text] [Related]
31. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
[TBL] [Abstract][Full Text] [Related]
32. The MLH1 -93 promoter variant influences gene expression.
Mei M; Liu D; Dong S; Ingvarsson S; Goodfellow PJ; Chen H
Cancer Epidemiol; 2010 Feb; 34(1):93-5. PubMed ID: 20060799
[TBL] [Abstract][Full Text] [Related]
33. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies.
Xu JL; Yin ZQ; Huang MD; Wang XF; Gao W; Liu LX; Wang RS; Huang PW; Yin YM; Liu P; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):901-7. PubMed ID: 22631669
[TBL] [Abstract][Full Text] [Related]
34. Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Hubner RA; Houlston RS
J Natl Cancer Inst; 2007 Oct; 99(19):1490; author reply 1490-1. PubMed ID: 17895478
[No Abstract] [Full Text] [Related]
35. The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis.
Pan XM; Yang WZ; Xu GH; Bai P; Qin HJ; Zhang LS; Zhai XD; Tang M; Deng W; Zhang L; Gao LB
Mutagenesis; 2011 Sep; 26(5):667-73. PubMed ID: 21745804
[TBL] [Abstract][Full Text] [Related]
36. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
37. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
[TBL] [Abstract][Full Text] [Related]
38. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan.
Djansugurova L; Zhunussova G; Khussainova E; Iksan O; Afonin G; Kaidarova D; Parker MI
Tumour Biol; 2015 Jan; 36(1):279-89. PubMed ID: 25249451
[TBL] [Abstract][Full Text] [Related]
39. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract][Full Text] [Related]
40. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
